Personalized T cells could offer an immunotherapy option to children with brain tumors
Personalized T cells could offer an immunotherapy option to children [...]
J&J previews $60B-a-year future with plans to go after viruses that have long evaded vaccine makers
J&J previews $60B-a-year future with plans to go after viruses [...]
Novo Nordisk bets big on RNAi, paying $3.3B to buy Dicerna
Novo Nordisk bets big on RNAi, paying $3.3B to buy [...]
Gilead hits go on a host of Arcus cancer programs but forgoes rumored buyout in a $725M pact as TIGIT leads the way
Gilead hits go on a host of Arcus cancer programs [...]
With FDA scrutinizing its data, AstraZeneca shows durability of COVID-preventing antibodies
With FDA scrutinizing its data, AstraZeneca shows durability of COVID-preventing [...]
Psychedelic psilocybin cuts cravings and boosts key brain functions in rat models of alcohol use disorder
Psychedelic psilocybin cuts cravings and boosts key brain functions in [...]
Valo whacks SPAC merger, blaming ‘market conditions’ for end of $750M Khosla deal
Valo whacks SPAC merger, blaming ‘market conditions’ for end of [...]
Eloxx ends long wait for phase 2 cystic fibrosis data. Market shrugs
Eloxx ends long wait for phase 2 cystic fibrosis data. [...]
Fine-tuning targeted therapy for multiple myeloma with ‘multi-omics’ data
Fine-tuning targeted therapy for multiple myeloma with ‘multi-omics’ data aliu [...]
Novartis-partnered DARPin flames out in COVID-19 study, sending Molecular Partners’ stock into nosedive
Novartis-partnered DARPin flames out in COVID-19 study, sending Molecular Partners’ [...]